Ph I/II Study of ColoAd1 Intraperitoneally in Ovarian Cancer Patients

• Research type

  Research Study

• Full title

  A Clinical Study Of ColoAd1 Administered Intraperitoneally: Dose Finding and Proof of Concept in Platinum-Resistant Epithelial Ovarian Cancer.

• IRAS ID

  139514

• Contact name

  Iain McNeish

• Contact email

  i.mcneish@imperial.ac.uk

• Sponsor organisation

  PsiOxus Therapeutics Ltd

• Eudract number

  2013-001276-38

• REC name

  London - Westminster Research Ethics Committee

• REC reference

  13/LO/1796

• Date of REC Opinion

  4 Dec 2013

• REC opinion

  Favourable Opinion